Medical Oncologist
CION Cancer Clinics
Intrahepatic cholangiocarcinoma: what it is and how it is treated | CION Cancer Clinics
Intrahepatic cholangiocarcinoma is a cancer that starts in the small bile ducts running through the liver. It is a primary liver cancer, but it is a different disease from the commoner HCC, and it is often first mistaken for cancer that spread from elsewhere. This page explains what it is, how it is confirmed, why the tumour should be tested for gene changes, and how treatment is decided. At CION Cancer Clinics in Hyderabad, our oncologists explain liver cancer in plain words and plan care around you and your family.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed October 2026, next review due October 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
The short answer
What is intrahepatic cholangiocarcinoma?
Intrahepatic cholangiocarcinoma is a cancer that starts in the small bile ducts inside the liver. It is a primary liver cancer, which means it began in the liver itself and did not spread there from somewhere else.
Why the name is so long
Break it into parts and it is easier. "Intrahepatic" means inside the liver. "Cholangio" means bile duct. "Carcinoma" means a cancer that starts in the lining cells of an organ. Bile ducts are thin tubes that carry bile, the digestive juice the liver makes, out towards the gut. A branching network of them runs right through the liver.
Which reader this page is for
This page is for someone told the cancer started in the bile ducts within the liver. It is not about cancer that spread to the liver from the bowel, breast or pancreas. If your report says "liver metastases", read primary versus secondary liver cancer first. It is also not about the more common primary liver cancer, hepatocellular carcinoma (HCC), which starts in the main liver cells.
Why it is its own disease
How is it different from other liver cancers?
It sits in the liver, but it behaves, looks and is treated differently from HCC. Four differences matter most.
It often grows in a healthy liver
HCC usually grows in a liver already scarred by hepatitis, alcohol or fatty liver disease. Intrahepatic cholangiocarcinoma can appear in a liver that was working perfectly well. Many people have no known liver condition at all.
It is easily mistaken for spread
Under the microscope it looks like an adenocarcinoma, the same type of cancer that starts in the bowel, stomach or pancreas. Doctors often search for a primary cancer elsewhere first. That search is sensible, but it can delay the right answer.
More on this in why it is mistaken for secondary cancer.It needs a biopsy
HCC can sometimes be diagnosed from a scan alone. This cancer almost always needs a sample of tissue, read by a pathologist, before treatment is planned.
It often carries a treatable gene change
A meaningful share of these tumours carry a specific DNA change that a targeted medicine can act on. That is why the tumour should be tested, and why the test is part of the plan, not an extra.
Changes doctors look for
- FGFR2 fusions
- IDH1 mutations
- HER2, BRAF and MSI, less often
Not sure whether this applies to you?
Ask an oncologistFrom scan to plan
How do doctors confirm it and plan treatment?
A scan finds a mass in the liver
Often it is found on an ultrasound done for vague pain, weight loss or a blood test that came back odd. Sometimes it is found by accident. Jaundice is less common than in bile duct cancers outside the liver, because the main ducts are not blocked early.
Detailed imaging maps the tumour
A contrast CT or MRI of the liver shows the size of the tumour, whether there are others, and how close it sits to the main blood vessels. A chest scan, and sometimes a PET-CT, checks for spread. CION arranges these through accredited diagnostic partners.
A biopsy confirms the cell type
A thin needle takes a small core of tissue. A pathologist uses special stains to tell this cancer apart from spread from another organ. Read why a biopsy is needed here if you have been told it is risky.
Blood tests and a search for another primary
Liver function tests and the marker CA 19-9 are usually checked. An endoscopy or a colonoscopy may be advised to rule out a bowel or stomach cancer that has spread.
The tissue is sent for molecular testing
The same biopsy sample is tested for DNA changes. Asking for this early saves a second biopsy later.
The tumour board decides
Medical oncologists, surgical oncologists, radiologists and pathologists review the case together and agree a plan.
The treatment picture
What are the treatment options?
The plan depends on one question first: can the tumour be removed completely with surgery? If it can, and the person is fit enough, surgery offers the best chance of long-term control. If it cannot, treatment with medicines aims to slow the cancer and keep the person well.
When surgery is possible
Surgery removes the part of the liver holding the tumour, with a margin of healthy tissue and nearby lymph nodes. This is a liver resection. CION's surgical oncologists assess and plan the operation, and your team will tell you where it takes place. Many people are then offered chemotherapy tablets or a drip afterwards, to lower the chance of the cancer coming back.
When surgery is not possible
For most people with advanced disease, the first treatment combines chemotherapy, usually gemcitabine with cisplatin, with an immunotherapy medicine such as durvalumab or pembrolizumab. Your oncologist will check which of these are available and approved in India at the time, and what each one costs. Some people also receive liver-directed treatment such as Y-90 or radiation, coordinated through partner hospitals.
When a gene change is found
If testing finds an FGFR2 fusion, an IDH1 mutation or another actionable change, a targeted medicine such as pemigatinib or ivosidenib may be an option, usually after first-line treatment. Not every one is approved in India, and some are reached only through import or a clinical trial. See targeted therapy for bile duct cancer for how these medicines work.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
On your report
What do the words on the report mean?
- Adenocarcinoma
- A cancer of gland-forming cells. It tells you the cell type, not yet the organ it started in.
- CK7 and CK20
- Stains the pathologist uses to work out where an adenocarcinoma probably began. A certain pattern points towards the bile ducts.
- Mass-forming
- The tumour has grown as a single lump inside the liver. This is the most common pattern for this cancer.
- Resectable
- The surgeon believes the whole tumour can be removed while leaving enough healthy liver behind.
- CA 19-9
- A blood marker that is often raised in bile duct cancer. It is also raised by blocked bile ducts and infection, so it cannot diagnose the cancer on its own.
- Molecular profiling
- Testing the tumour's DNA for changes that a targeted medicine can act on. You may also see it called NGS, short for next-generation sequencing.
Did you know
The same biopsy tissue can be used for both the diagnosis and the molecular test. Ask early whether the sample is large enough for both, so nobody has to go back for a second needle. Read why molecular testing matters.
Being straight with you
What this page cannot tell you
It cannot tell you whether the mass on your scan is this cancer. Only a biopsy read by a pathologist, alongside your scans, can answer that. Many liver masses turn out to be something else, including harmless lumps, an abscess or spread from another organ.
It cannot tell you what will happen to you
Outlook depends on the size and number of tumours, whether lymph nodes are involved, whether surgery is possible, your general fitness and what the molecular test finds. No page can weigh those for one person. Your oncologist can explain what your own results mean.
Who this does not apply to
It does not apply to cancer that spread to the liver from the bowel, which is planned by the colon cancer team, or to gallbladder cancer. It does not apply to children, whose liver tumours are a different disease. If you are not sure which group your report puts you in, bring it to a consultation and ask.
If you have a report and are unsure what it says, call the helpline. Someone will help you find the right specialist.Questions we are asked
Common questions about intrahepatic cholangiocarcinoma
Is intrahepatic cholangiocarcinoma the same as liver cancer?
It is one kind of primary liver cancer. The commonest kind is hepatocellular carcinoma, which starts in the main liver cells. This one starts in the bile duct cells inside the liver. The two are tested, staged and treated differently, so the exact name on your report matters.
Is it the same as bile duct cancer?
It is the type of bile duct cancer that grows inside the liver. Bile duct cancers can also start where the ducts leave the liver, or lower down near the pancreas. Those other types more often cause early jaundice and are usually operated on in a different way.
What causes it?
Often no cause is found. Long-term inflammation of the bile ducts raises the risk, including primary sclerosing cholangitis, bile duct stones, liver fluke infection and choledochal cysts. Hepatitis B or C, cirrhosis, fatty liver disease and diabetes are also linked. Having a risk factor does not mean anyone did anything wrong.
Why did my doctor first think it had spread from somewhere else?
Because under the microscope it looks like cancers that start in the bowel, stomach or pancreas. A careful doctor rules those out first. Special stains on the biopsy, and scans or a scope of the gut, help confirm that the liver is where it began.
Is it curable?
When the tumour is found early and can be removed completely, treatment is given with curative intent. The cancer can still come back, so follow-up scans continue for years. When surgery is not possible, treatment aims to control the cancer and protect quality of life. Your oncologist can tell you which applies.
Does every patient need molecular testing?
Guidelines advise it for bile duct cancer, especially when surgery is not possible or the cancer has returned. It does not promise a targeted option. Many tumours carry no actionable change. When one is found, it can open a medicine that would otherwise never be considered.
Can a liver transplant treat this cancer?
For intrahepatic cholangiocarcinoma, transplant is not standard treatment. It is studied only in rare, carefully selected cases at specialist transplant centres, often in research settings. If someone suggests it, ask which centre would assess you and on what grounds.
What should our family do first?
Collect every scan, report and biopsy slide in one folder. Ask whether the tumour has been sent for molecular testing, and whether surgery has been considered by a surgical oncologist. Call the CION helpline if you want the case reviewed by the tumour board or a second opinion on the plan.
Your Specialists
Meet CION's liver cancer specialists. Bring your scan reports and liver blood tests.
Our medical and surgical oncologists plan liver cancer care together, weighing the tumour and how well your liver works before choosing surgery, a liver-directed procedure or medicines.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- American Cancer Society — What Is Bile Duct Cancer?
- National Cancer Institute — Bile Duct Cancer Treatment
- American Cancer Society — Bile Duct Cancer Targeted Therapy
- Cancer Research UK — Bile duct cancer (Cholangiocarcinoma)
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
How cholangiocarcinoma differs from HCCThe two primary liver cancers, side by sideHow intrahepatic cholangiocarcinoma is diagnosedEvery scan and test, in the order they usually happenWhy every biliary cancer should be molecularly testedThe DNA test that can open a targeted optionIs intrahepatic cholangiocarcinoma curable?When surgery aims for long-term control, and when it cannot
Talk to us
Has the biopsy been sent for molecular testing?
If you have a diagnosis or a report you are unsure about, our tumour board can review the scans, the biopsy and the plan with you. One helpline serves every CION centre.